 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

Current Price	$6.00
Prev Close	$6.28
Open	$6.33
Dividend Yield	0.00%
50-Day Moving Average	$7.35
Beta	1.02
Avg. Volume	260,068.14
PE Ratio	-1.59

52-Week High	$10.30
52-Week Low	$2.00
Market Capitalization	$126.24M
EPS	-$3.77
Price to Book	242.82
Revenue Per Employee	N/A
Enterprise Value/EBITDA	-2.91

ACHV Achieve Life Sciences Inc.

About

Feed

Fundamentals

News